Shingles: Clinical Trials

5 trials for Shingles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
JCXH-105, Active Control (Shingrix) - Herpes Zoster (HZ), Shingles
Phase 1CompletedImmorna Biotherapeutics, Inc.752023-05-262024-09-19
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers
Z-1018, Shingrix - Shingles, Herpes Zoster
Phase 1CompletedDynavax Technologies Corporation1502022-01-102022-11-07
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Zostavax, HZ/su vaccine, Placebo - Shingles, Herpes Zoster
Phase 1CompletedUniversity of Colorado, Denver1602014-05-012020-07-08
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Varicella Zoster Virus Vaccine (Zostavax) - Immunosenescence, Shingles
Phase 1CompletedUniversity of Colorado, Denver332010-11-012021-06-25
Valacyclovir in Immunocompromised Children
Valacyclovir - Shingles, Bone Marrow Transplantation
Phase 1CompletedBaylor College of Medicine371998-04-072020-03-04

Narrower conditions

Herpes Zoster (5)  ·  Chickenpox (1)  ·  Communicable Diseases (1)  ·  Vaccine-Preventable Diseases (1)

Broader conditions

DNA Virus Infections (5)  ·  Herpesviridae Infections (5)  ·  Infections (5)  ·  Varicella Zoster Virus Infection (5)  ·  Virus Diseases (5)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Herpes Zoster Vaccine (2)  ·  Saline Solution (1)  ·  Vaccines, Synthetic (1)  ·  Valacyclovir (1)

Sponsors

University of Colorado, Denver (2)  ·  Baylor College of Medicine (1)  ·  Dynavax Technologies Corporation (1)  ·  Immorna Biotherapeutics, Inc. (1)

Countries

United States (4)  ·  Australia (1)

Top investigators

Adit A Ginde, MD, MPH (1)  ·  Myron J Levin, M.D. (1)  ·  Susan Blaney, MD (1)

Results publications

PMID 30247596, PMID 34850039, PMID 37781954

NIH funding

K23AG040708 (1)